From research through clinical development
Aldevron provides a one-vendor strategy for preclinical through GMP gene editing nucleases. Using Cas9 in protein form provides many benefits, including reduced off-target effects, immediate intracellular activity and controlled dosage capabilities. Aldevron gene editing nucleases are available as catalog products in standard formulations and can be custom manufactured to meet your exact needs.
Our enzymes are engineered to be used in a variety of applications including electroporation, transfection and microinjection. We provide several options for research, GMP-Source™ (GMP-S) and GMP quality grades, providing a seamless transition from research through clinical stages of development.